Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)

BACKGROUND: Until 50% of patients with renal cancer or melanoma, develop brain metastases during the course of their disease. Stereotactic radiotherapy has become a standard of care for patients with a limited number of brain metastases. Given the radioresistant nature of melanoma and renal cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesueur, Paul, Lequesne, Justine, Barraux, Victor, Kao, William, Geffrelot, Julien, Grellard, Jean-Michel, Habrand, Jean-Louis, Emery, Evelyne, Marie, Brigitte, Thariat, Juliette, Stefan, Dinu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064124/
https://www.ncbi.nlm.nih.gov/pubmed/30055640
http://dx.doi.org/10.1186/s13014-018-1083-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064124/
https://www.ncbi.nlm.nih.gov/pubmed/30055640
http://dx.doi.org/10.1186/s13014-018-1083-1

Ejemplares similares